Key points are not available for this paper at this time.
See the associated articles on pages 9091 and 9152. The last 2 years have brought significant progress for the clinical use of somatostatin receptor (SSR) targeted imaging and therapy in the United States. In 2016, the Food and Drug Administration approved 68Ga-DOTATATE for imaging of
Bodei et al. (2018) studied this question.